Myelodysplastic syndromes (MDS)
EBM Guidelines
Jan 25, 2024 • Latest change Aug 22, 2025
Table of contents
Extract
- Myelodysplastic syndromes (MDS) are malignant blood diseases characterized by decreased haematological values and a tendency to develop into acute leukaemia.
- MDS should be suspected particularly in an elderly patient with unexplained macrocytic anaemia, which may be associated with leucopenia or thrombocytopenia.
- Cytopenias in the blood count result from inefficient bone marrow function caused by dysplasia i.e. a disorder of differentiation and maturation of myeloid cell lines.
Search terms
Bone Marrow Examination, D46*, Erythrocyte Transfusion, Haematology, Hemoglobins, Internal medicine, Myelodysplastic Syndromes, allogeneic stem-cell transplantation, ringed sideroblast